Hyun A Lee

发表

A physiologically‐based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K+‐competitive acid blocker

K. Yu, Howard Lee, S. Jang, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

A target‐mediated drug disposition population pharmacokinetic model of GC1118, a novel anti‐EGFR antibody, in patients with solid tumors

Y. Bang, J. W. Kim, Keun-Wook Lee, 2020, Clinical and translational science.

Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials

Eunwoo Kim, K. Yu, I. Song, 2018, Pharmaceutical Research.

A population PK–PD model of YH4808, a novel P‐CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808

K. Yu, Howard Lee, S. Jang, 2022, CPT: pharmacometrics & systems pharmacology.

A Machine Learning-Based Identiﬁcation of Genes A ﬀ ecting the Pharmacokinetics of Tacrolimus Using the DMET TM Plus Platform

Jeong-An Gim, Hyun A Lee, Kyeong-Ryoon Lee, 2020 .

Development of a physiologically-based pharmacokinetic model for cyclosporine in Asian children with renal impairment

Sumin Yoon, K. Yu, Jae-Yong Chung, 2019, Translational and clinical pharmacology.

YH12852, a Potent and Selective Receptor Agonist of 5‐hydroxytryptamine, Increased Gastrointestinal Motility in Healthy Volunteers and Patients With Functional Constipation

Hyun A Lee, H. Yoo, Mi Kyung Kim, 2020, Clinical and translational science.

A Machine Learning-Based Identification of Genes Affecting the Pharmacokinetics of Tacrolimus Using the DMETTM Plus Platform

Jeong-An Gim, Hyun A Lee, Kyeong-Ryoon Lee, 2020, International journal of molecular sciences.

URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers.

Sang-In Park, K. Yu, Hyun A Lee, 2019, Rheumatology.

Development of a Korean‐specific virtual population for physiologically based pharmacokinetic modelling and simulation

Sumin Yoon, K. Yu, O. Hatley, 2019, Biopharmaceutics & drug disposition.

A population pharmacokinetic‐pharmacodynamic model of YH12852, a highly selective 5‐hydroxytryptamine 4 receptor agonist, in healthy subjects and patients with functional constipation

S. Jang, Hyun A Lee, Howard Lee, 2021, CPT: pharmacometrics & systems pharmacology.

Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials

Eunwoo Kim, K. Yu, I. Song, 2018, Pharmaceutical Research.

A randomized, double-blind, three-arm, parallel group, single-dose phase I study to evaluate the pharmacokinetic similarity between SB12 (a proposed eculizumab biosimilar) and eculizumab (Soliris) in healthy subjects

Hyun A Lee, Younsoo Kim, R. Fuhr, 2022, International journal of clinical pharmacology and therapeutics.